Bromide

Bromide

SCHEMBL28116

Br.CN(C)CCBr

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565 0.96
Hydrochloric Acid SCHEMBL659254 0.92
Bromide SCHEMBL710126 0.79
Sulfuric Acid SCHEMBL11650367 0.78 ALDH1A1 (0.41)
SCHEMBL29988628 0.78 MAPT (0.36)
Bromide SCHEMBL7639265 0.76
SCHEMBL895778 0.74
Bromide SCHEMBL29063575 0.74 ALDH1A1 (0.65)
Bromide SCHEMBL9491844 0.74 ALDH1A1 (0.65)
Bromide SCHEMBL29063564 0.74 ALDH1A1 (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118746635-A Derivatization detection method for free fatty acid in tea 中国农业科学院茶叶研究所 2024-10-08 CN claimed
CN-116693747-A Viscosity-increasing type temperature-resistant salt-tolerant polymer filtrate reducer and preparation method and application thereof 长江大学 2023-09-05 CN claimed
US-5702887-A BENZ(B)ACRIDINIUM-12-CARBOXYLATE COMPOUNDS CHIRON DIAGNOSTICS CORPORATION (US) 1997-12-30 US claimed
US-20260137706-A1 METHODS OF TREATING INFLAMMATORY DISEASES INTERLINE THERAPEUTICS INC (US) 2026-05-21 US disclosed
EP-4743453-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION Pretzel Therapeutics, Inc. (US) 2026-05-20 EP disclosed
EP-4735422-A1 SUBSTITUTED CYCLIC COMPOUNDS AND METHODS OF TREATING PHENYLKETONURIA AND OTHER AMINO ACIDURIAS Sanofi (FR) 2026-05-06 EP disclosed
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 EP disclosed
US-20260085077-A1 HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2026-03-26 US disclosed
US-20260083674-A1 OXAZOLIDINONE LIPOSOME COMPOSITIONS AKAGERA MEDICINES, INC. (US) 2026-03-26 US disclosed
US-20260078117-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS INC (US) 2026-03-19 US disclosed
EP-4711356-A1 TETRAHYDROCARBAZOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND USE THEREOF Nain Biotech (Hangzhou) Co., Ltd. (CN) 2026-03-18 EP disclosed
US-5395752-A Detecting emission signals of conjugates of angular or linear four ring or three ring acridinium compounds CIBA CORNING DIAGNOSTICS CORP. (US) 1995-03-07 US disclosed
WO-1994021823-A1 LONG EMISSION WAVELENGTH CHEMILUMINESCENT COMPOUNDS AND THEIR USE IN TEST ASSAYS CIBA CORNING DIAGNOSTICS CORP. (US) 1994-09-29 WO disclosed
EP-0617288-A2 Long emission wavelength chemiluminescent compounds and their use in test assays CIBA-GEIGY AG (CH) 1994-09-28 EP disclosed
US-4874788-A BACTERICIDES ETHYL CORPORATION (US) 1989-10-17 US disclosed
US-4874789-A BACTERICIDES ETHYL CORPORATION (US) 1989-10-17 US disclosed
US-4874785-A BACTERICIDES ETHYL CORPORATION (US) 1989-10-17 US disclosed
US-4874784-A BACTERICIDES ETHYL CORPORATION (US) 1989-10-17 US disclosed
US-4824867-A BACTERICIDES ALBERMARLE CORPORATION 1989-04-25 US disclosed
US-4748239-A VASODILATORS E. R. SQUIBB & SONS, INC. (US) 1988-05-31 US disclosed